Back to search
FDAFDA · Food and drugs·Recall number D-0631-2022

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

Published February 23, 2022 · Recall initiated: August 2, 2021

Summary

FDA records drug Class I recall D-0631-2022, published February 23, 2022 and initiated August 2, 2021. Recalling firm: Je Dois Lavoir LLC; Status: Terminated; Reported quantity: 783 bottles; Lot: Lot 102-26, Exp Dec 2022. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Je Dois Lavoir LLC
Distributor
Sold online via website nationwide in the USA and Canada.
Lot
Lot 102-26, Exp Dec 2022
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL recalled?

Yes. FDA published recall D-0631-2022 on February 23, 2022. Reported hazard: Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release